Cupid Ltd

Cupid Ltd

₹ 101 -1.26%
10 Jun - close price
About

Established in 1993, CUPID Limited is India's premier manufacturer of male and female condoms, personal lubricant, and IVD kits.[1]

Key Points

Products Offered[1]
The Co. manufactures male condoms, female condoms, water-based lubricant jelly, IVD products such as Pregnancy Test Kits, Covid 19 Antigen Test Kit, HIV Test Kit, Dengue test kits, Malaria antigen test kits, etc.

  • Market Cap 2,728 Cr.
  • Current Price 101
  • High / Low 114 / 50.0
  • Stock P/E 66.6
  • Book Value 12.8
  • Dividend Yield 0.00 %
  • ROCE 16.9 %
  • ROE 12.7 %
  • Face Value 1.00

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 7.95 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoters have pledged 40.5% of their holding.
  • Debtor days have increased from 93.9 to 120 days.
  • Working capital days have increased from 203 days to 370 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
32 31 46 43 42 35 36 40 66 44 47 51 61
25 25 33 29 31 32 29 28 32 32 31 35 43
Operating Profit 8 6 13 14 11 3 7 12 34 12 16 16 18
OPM % 23% 21% 28% 33% 26% 9% 20% 30% 51% 26% 34% 31% 30%
0 0 0 0 2 0 0 1 0 0 0 0 0
Interest 0 0 0 0 1 0 0 0 1 0 1 0 1
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax 7 6 12 13 11 2 6 12 32 11 14 14 16
Tax % 38% 19% 30% 24% 25% 3% 20% 24% 26% 22% 29% 21% 28%
4 5 9 10 8 2 5 9 24 8 10 11 12
EPS in Rs 0.16 0.17 0.32 0.38 0.31 0.08 0.19 0.33 0.89 0.31 0.37 0.41 0.43
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
20 44 61 84 81 85 160 143 133 159 171 203
17 32 36 50 53 65 108 107 109 118 121 142
Operating Profit 2 13 25 34 27 21 52 36 23 41 50 61
OPM % 10% 29% 41% 41% 34% 24% 33% 25% 17% 26% 29% 30%
0 1 2 1 1 2 3 5 4 5 7 0
Interest 0 0 0 0 0 0 1 1 0 1 2 2
Depreciation 2 2 2 2 2 2 2 3 3 3 3 4
Profit before tax 0 11 25 32 26 21 53 38 25 42 53 55
Tax % 60% 33% 36% 37% 34% 27% 24% 24% 30% 25% 24% 25%
0 8 16 21 17 15 40 29 17 32 40 41
EPS in Rs 0.00 0.29 0.60 0.77 0.64 0.57 1.49 1.09 0.65 1.18 1.49 1.52
Dividend Payout % 0% 22% 21% 22% 29% 35% 15% 21% 35% 21% 0% 0%
Compounded Sales Growth
10 Years: 16%
5 Years: 5%
3 Years: 15%
TTM: 19%
Compounded Profit Growth
10 Years: 18%
5 Years: 1%
3 Years: 35%
TTM: 6%
Stock Price CAGR
10 Years: 42%
5 Years: 63%
3 Years: 109%
1 Year: 6%
Return on Equity
10 Years: 21%
5 Years: 16%
3 Years: 16%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 11 11 11 11 11 13 13 13 13 13 13 27
Reserves 7 13 25 43 55 63 90 118 129 154 288 315
3 2 1 0 2 2 31 0 9 6 12 19
5 8 14 9 10 15 30 22 23 16 7 11
Total Liabilities 27 35 51 63 78 93 165 152 174 189 320 372
16 16 16 16 16 21 26 29 31 36 58 67
CWIP 0 0 0 0 0 0 3 1 6 0 0 6
Investments 0 0 0 5 18 22 21 48 54 69 135 103
10 19 35 42 44 50 114 74 84 83 126 196
Total Assets 27 35 51 63 78 93 165 152 174 189 320 372

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 7 13 20 3 18 19 42 10 33 8 -11
-0 -1 -1 -5 -9 -14 -37 -9 -13 -22 -80 45
1 -3 -6 -4 -3 -5 16 -33 3 -11 99 -1
Net Cash Flow 0 3 6 11 -9 -0 -2 0 -1 -0 27 32

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 59 67 79 59 100 97 95 65 84 59 102 120
Inventory Days 165 155 60 133 259 168 437 230 197 229 184 226
Days Payable 81 84 27 80 162 135 579 168 134 105 1 7
Cash Conversion Cycle 144 139 112 112 198 130 -46 127 147 183 286 340
Working Capital Days 120 76 82 67 140 118 111 87 111 91 149 370
ROCE % 3% 48% 79% 72% 43% 29% 50% 28% 17% 26% 22% 17%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
45.06% 45.06% 45.06% 45.06% 45.06% 45.06% 45.06% 44.80% 44.80% 45.62% 42.51% 42.51%
0.65% 0.59% 0.58% 0.66% 0.45% 0.34% 0.45% 5.19% 5.97% 3.33% 3.14% 1.63%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.11%
54.28% 54.35% 54.36% 54.28% 54.49% 54.60% 54.49% 50.00% 49.24% 51.05% 54.34% 55.75%
No. of Shareholders 29,41429,02927,22626,33326,43428,15425,58233,76195,6391,12,2361,16,3741,23,379

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls